Clinical Trials Directory

Trials / Completed

CompletedNCT02493959

Degradation of the Anorexic Hormone Peptide YY

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Peptide YY (PYY) is a gastrointestinal hormone released from the enteroendocrine cell upon food intake. The N-terminal truncated form, PYY3-36, exerts anorexic effects. In this study we want to investigate the kinetics of PYY1-36 and PYY3-36 and to examine whether a C-terminally degraded metabolite, PYY3-34, is formed after infusion of PYY.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPYY1-36 infusionInfusion of 1.6 pmol/kg/min PYY1-36 for 2 hrs.
BIOLOGICALPYY1-36 + sitagliptinInfusion of 1.6 pmol/kg/min PYY1-36 for 2 hrs. Two doses of 100 mg sitagliptin are administered 10 and 1 hour before start of infusion, respectively.
BIOLOGICALPYY3-36 infusion0.8 pmol/kg/min infusion of PYY3-36.
BIOLOGICALplaceboInfusion of saline for 2 hrs.

Timeline

Start date
2014-05-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2015-07-10
Last updated
2015-07-10

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02493959. Inclusion in this directory is not an endorsement.